Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18768
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMetcalfe, Sylvia A-
dc.contributor.authorMartyn, Melissa-
dc.contributor.authorAmes, Alice-
dc.contributor.authorAnderson, Vicki-
dc.contributor.authorArchibald, Alison D-
dc.contributor.authorCarter, Rob-
dc.contributor.authorCohen, Jonathan-
dc.contributor.authorCotter, Megan-
dc.contributor.authorGenCouns, M-
dc.contributor.authorDang, William-
dc.contributor.authorDelatycki, Martin B-
dc.contributor.authorDonath, Susan-
dc.contributor.authorEdwards, Samantha-
dc.contributor.authorEduc, PGrad Dip-
dc.contributor.authorForbes, Robin-
dc.contributor.authorGavrila, Mioara-
dc.contributor.authorMedSci, M-
dc.contributor.authorHalliday, Jane-
dc.contributor.authorHickerton, Chriselle-
dc.contributor.authorHill, Melissa-
dc.contributor.authorJacobs, Lorilli-
dc.contributor.authorUltrasound, PGrad Dip-
dc.contributor.authorPetrou, Vicki-
dc.contributor.authorPlunkett, Loren-
dc.contributor.authorSheffield, Leslie-
dc.contributor.authorRacp, F-
dc.contributor.authorThornton, Alison-
dc.contributor.authorCouns, Grad Dip Gen-
dc.contributor.authorYounie, Sandra-
dc.contributor.authorEcon, PGrad Dip Hlth-
dc.contributor.authorEmery, Jon D-
dc.date2017-06-29-
dc.date.accessioned2018-08-31T06:05:34Z-
dc.date.available2018-08-31T06:05:34Z-
dc.date.issued2017-12-
dc.identifier.citationGenetics in medicine : official journal of the American College of Medical Genetics 2017; 19(12): 1346-1355-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/18768-
dc.description.abstractPurposePopulation-based carrier screening for fragile X syndrome (FXS) is still not universally endorsed by professional organizations due to concerns around genetic counseling for complex information and potential for psychosocial harms.MethodsWe determined uptake levels, decision making, and psychosocial impact in a prospective study of pregnant and nonpregnant Australian women offered FXS carrier screening in clinical settings. Women received pretest genetic counseling, and completed questionnaires when deciding and one month later.ResultsOf 1,156 women recruited, 83.1% returned the first questionnaire with 70.6% nonpregnant and 58.8% pregnant women choosing testing (χ2=16.98, P<0.001). Overall, informed choice was high in both nonpregnant (77.4%) and pregnant (72.9%) women (χ2=0.21, P=0.644), and more tested (76.0%) than not-tested (66.7%) women (χ2=6.35, P=0.012) made an informed choice. Measures of depression, stress, and anxiety were similar to population norms for ~85% of women. Decisional conflict and regret were generally low; however, decisional uncertainty and regret were greater in pregnant than nonpregnant women, and not-tested than tested women (uncertainty: χ2=18.51, P<0.001 and χ2=43.11, P<0.001, respectively; regret: χ2=6.61, P<0.037 and χ2=35.54, P<0.001, respectively).ConclusionWe provide evidence to inform guidelines that population FXS carrier screening can be implemented with minimal psychosocial harms following appropriate information and prescreening genetic counseling.-
dc.language.isoeng-
dc.titleInformed decision making and psychosocial outcomes in pregnant and nonpregnant women offered population fragile X carrier screening.-
dc.typeJournal Article-
dc.identifier.journaltitleGenetics in medicine : official journal of the American College of Medical Genetics-
dc.identifier.affiliationMurdoch Childrens Research Institute, Melbourne, Victoria, Australia-
dc.identifier.affiliationDepartment of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia-
dc.identifier.affiliationRoyal Children's Hospital, Melbourne, Victoria, Australia-
dc.identifier.affiliationVictorian Clinical Genetics Services, Melbourne, Victoria, Australia-
dc.identifier.affiliationFaculty of Health, Deakin Health Economics, Deakin University, Melbourne, Victoria, Australia-
dc.identifier.affiliationFragile X Alliance Clinic and Centre for Developmental Disability Health Victoria, Monash University, Melbourne, Victoria, Australia-
dc.identifier.affiliationAustin Health, Heidelberg, Victoria, Australia-
dc.identifier.affiliationAustralian Clinical Labs (formerly Healthscope Pathology), Clayton, Victoria, Australia-
dc.identifier.affiliationSchool of Primary Aboriginal and Rural Health Care, University of Western Australia-
dc.identifier.affiliationGreat Ormond Street Hospital for Children, London, UK-
dc.identifier.affiliationMyDNA Life Australia, Melbourne, Victoria, Australia-
dc.identifier.affiliationDepartment of General Practice, The University of Melbourne, Melbourne, Victoria, Australia-
dc.identifier.doi10.1038/gim.2017.67-
dc.identifier.pubmedid28661491-
dc.type.austinJournal Article-
dc.type.austinResearch Support, Non-U.S. Gov't-
local.name.researcherCotter, Megan
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptClinical Genetics-
crisitem.author.deptClinical Genetics-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

16
checked on Feb 23, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.